PREVALENCE OF LEPTOMENINGEAL CONTRAST ENHANCEMENT IN MULTIPLE SCLEROSIS VERSUS OTHER CHRONIC NEUROINFLAMMATORY DISEASES (S2.007) — Martina Absinta (2017) | RDL Network
PREVALENCE OF LEPTOMENINGEAL CONTRAST ENHANCEMENT IN MULTIPLE SCLEROSIS VERSUS OTHER CHRONIC NEUROINFLAMMATORY DISEASES (S2.007)
Article 2017 en
Authors
MA
Martina Absinta
IC
Irene Cortese
LV
Luisa Vuolo
Abstract
1 min read
We aimed to assess the prevalence and the specificity of leptomeningeal enhancement (LME) in multiple sclerosis (MS) compared to a variety of inflammatory and non-inflammatory neurological conditions assessed in two academic research hospitals.
Martina Absinta, Irene Cortese, Luisa Vuolo, Govind Nair, Manori P. de Alwis, Joan Ohayon, Alessandro Meani, Vittorio Martinelli, Roberta Scotti, Andrea Falini, Bryan Smith, Avindra Nath, Steven Jacobson, Massimo Filippi, Daniel S. Reich
Pietro Maggi, Pascal Sati, Govind Nair, Irene Cortese, Steven Jacobson, Bryan Smith, Avindra Nath, Joan Ohayon, Vincent Van Pesch, Gaetano Perrotta, Caroline Pot, Marie Théaudin, Vittorio Martinelli, Roberta Scotti, Tianxia Wu, Renaud Du Pasquier, Peter A. Calabresi, Massimo Filippi, Daniel H. Reich, Martina Absinta
Paolo Preziosa, Svenja Kiljan, Martijn D. Steenwijk, Alessandro Meani, Wilma D. J. van de Berg, Geert J. Schenk, Maria A. Rocca, Massimo Filippi, Jeroen J.G. Geurts, Laura E. Jonkman
Tyler MacDonald, John D. Fisk, Çharles N. Bernstein, Renée El‐Gabalawy, Carol Hitchon, Jennifer Kornelsen, Scott Burton Patten, Annaliese Tisseverasinghe, Ruth Ann Marrie
Discussion(0)
No comments yet. Be the first to comment.